Walgreens Boots Alliance Inc. (WBA)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Walgreens Agrees to Pay About $2.8 Million to Resolve Medicaid-Overbilling Allegations
Walgreens agreed to pay about $2.8 million to the federal government and the states of Massachusetts and Georgia to settle allegations that the company inflated prices for generic medications covered by Medicaid.
Should You Buy Walgreens Boots Alliance Stock Before It Goes Private?
Walgreens Boots Alliance (WBA -0.14%) may not be a publicly traded stock for much longer.
Walgreens Boots Alliance (WBA) Expected to Beat Earnings Estimates: Should You Buy?
Walgreens (WBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens Boots' Stefano Pessina to almost double stake after Sycamore takeover, FT reports
Walgreens Boots Alliance's executive chair Stefano Pessina will almost double his stake in the US pharmacy group to about 30% as part of its takeover by private equity group Sycamore, the Financial Times reported on Tuesday citing people familiar with the matter.
Walgreens Boots Alliance: Don't Write Off This Asset Champ Yet
Troubled pharmacy chain Walgreens Boots Alliance Inc. NASDAQ: WBA has been a spectacular disappointment since completing its merging in 2014. Shares rose to a high of $97.14 following the union but had since fallen % to a low of $8.11 on November 21.
Walgreens Boots Alliance: A Great Risk To Reward Opportunity With This $23.7 Billion Buyout
Walgreens Boots Alliance is being acquired by Sycamore Partners, causing shares to rise 7.5% to $11.39, though long-term shareholders face a 50.2% loss since January 2024. The deal includes a $23.7 billion enterprise value, with shareholders receiving $11.45 per share plus potential additional proceeds from VillageMD, though this extra compensation is uncertain. Despite challenges and declining profits, Walgreens Boots Alliance has shown revenue growth in core operations, suggesting the stock is undervalued even at the buyout price.
Walgreens stock gets a modest boost after the pharmacy chain agrees to be bought by private equity
Shares in Walgreens Boots Alliance, Inc. (Nasdaq: WBA) are up a modest amount after the company announced yesterday that it has agreed to be purchased by private equity firm Sycamore Partners. As of the time of this writing, WBA shares are up under 7% to $11.33.
Is Walgreens Boots Alliance (WBA) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Faber Report: Walgreens to go private
David Faber breaks down the latest details on Sycamore's acquisition of Walgreens.
Walgreens to go private in $10B deal with Sycamore: how the pharmacy giant fell from grace
Walgreens Boots Alliance will be taken private by Sycamore Partners in a $10 billion deal, the companies announced Thursday, marking the end of nearly a century of public trading for the US pharmacy giant.
Walgreens, from pharmacy behemoth to distressed retailer
Walgreens Boots Alliance is being taken private by Sycamore Partners for $10 billion, bringing to a close the pharmacy chain operator's nearly century-long association with the public markets.
Boots owner to be taken private in $10bn deal
The US owner of Boots set to be taken private in a $10 billion deal, ending nearly a century as a publicly traded company. US private equity firm Sycamore Partners will buy the Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A) for $11.45 per share, a price higher than its current market value.
